Nie, Esther H.
https://orcid.org/0000-0002-2280-5905
Mayo Clinic
Kyverna Therapeutics, Inc. (United States)
Citations 1
Design of KYSA-8, A Phase 2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Treatment-Refractory Stiff-Person Syndrome (P2-8.018)
Ζεκερίδου, Αναστασία , Nie, Esther H. , Chung, James , Piquet, Amanda L. , Borie, Dominic C. , Dalakas, Marinos C.
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available
